At DKMS, we continuously work to improve patients’ situation with blood cancer and other life-threatening blood disorders around the world. Driven by innovation, we aim to provide the best possible services for medical and healthcare professionals. On this platform, you will find comprehensive information on accessing our services, research and resources as well as grants and programs we offer to support your work.
The DKMS Registry makes donors from six of our donor centers available for international requests. Our experts provide information about their HLA characteristics to registries, search units and transplant centers around the world with the aim of finding the most suitable donor for patients as quickly as possible.
Originally established and still operating as a cord blood bank, our DKMS Stem Cell Bank is the first facility in the world which makes cryopreserved peripheral blood stem cells available for unrelated allogeneic stem cell transplantation.
Founded in 1997 and based in Dresden, Germany, the DKMS Life Science Lab became part of the DKMS Group in 2001. As the world’s leading HLA typing laboratory, our lab carries out typing according to the latest scientific standards and has achieved numerous milestones.
Established in 2016 and coordinated by our Clinical Trials Unit, the Collaborative Biobank (CoBi) is a cooperative science platform that provides resources for research projects in the field of blood cancer worldwide.